Breaking News Instant updates and real-time market news.

CSSE

Chicken Soup for the Soul

$32.50 /

+4.54 (+16.24%)

08:23
04/12/21
04/12
08:23
04/12/21
08:23

Chicken Soup for the Soul price target raised to $40 from $30 at Northland

Northland analyst Mike Grondahl raised the firm's price target on Chicken Soup for the Soul to $40 from $30 and keeps an Outperform rating on the shares following the company's recent agreement to acquire Sonar Entertainment, which he notes will increases the company's content library to over 2,000 TV episodes and 2,000 movies. Sonar fits directly with all Chicken Soup's expansion plans by increasing the original content library and development pipeline, as well as providing for faster international expansion, the analyst added.

  • 24

    May

CSSE Chicken Soup for the Soul
$32.50 /

+4.54 (+16.24%)

04/09/21 Alliance Global Partners
Alliance Global raises Chicken Soup for the Soul price target to $48 after deal
04/01/21 DA Davidson
Chicken Soup for the Soul price target raised to $34 from $28 at DA Davidson
04/01/21 Craig-Hallum
Chicken Soup for the Soul price target raised to $35 from $30 at Craig-Hallum
04/01/21 Northland
Chicken Soup for the Soul price target raised to $30 from $18 at Northland

TODAY'S FREE FLY STORIES

Hot Stocks
Terns Pharmaceuticals Inc trading resumes  07:35
06/14/21
06/14
07:35
06/14/21
07:35
TERN

Terns Pharmaceuticals

$17.45 /

-2.02 (-10.37%)

 
ShowHide Related Items >><<
TERN Terns Pharmaceuticals
$17.45 /

-2.02 (-10.37%)

TERN Terns Pharmaceuticals
$17.45 /

-2.02 (-10.37%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
  • 05
    Feb
TERN Terns Pharmaceuticals
$17.45 /

-2.02 (-10.37%)

Options
Unusual call flow in option market yesterday » 07:35
06/14/21
06/14
07:35
06/14/21
07:35
IVR

Invesco Mortgage

$4.24 /

-0.03 (-0.70%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IVR Invesco Mortgage
$4.24 /

-0.03 (-0.70%)

IVR Invesco Mortgage
$4.24 /

-0.03 (-0.70%)

12/14/20 Jefferies
Invesco Mortgage initiated with an Underperform at Jefferies
06/30/20 BofA
Invesco Mortgage initiated with an Underperform at BofA
  • 27
    May
  • 02
    Feb
IVR Invesco Mortgage
$4.24 /

-0.03 (-0.70%)

Hot Stocks
Humana to acquire One Homecare Solutions, terms undisclosed » 07:34
06/14/21
06/14
07:34
06/14/21
07:34
HUM

Humana

$418.96 /

-2.23 (-0.53%)

Humana announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUM Humana
$418.96 /

-2.23 (-0.53%)

HUM Humana
$418.96 /

-2.23 (-0.53%)

05/18/21 Wells Fargo
Humana initiated with an Equal Weight at Wells Fargo
04/29/21 Oppenheimer
Humana price target raised to $480 from $460 at Oppenheimer
04/29/21 Mizuho
Humana price target raised to $480 from $462 at Mizuho
04/29/21 Citi
Humana price target raised to $510 from $496 at Citi
HUM Humana
$418.96 /

-2.23 (-0.53%)

HUM Humana
$418.96 /

-2.23 (-0.53%)

Hot Stocks
Corporate digital learning company Skillsoft debuts on NYSE » 07:34
06/14/21
06/14
07:34
06/14/21
07:34
SKIL

Skillsoft

$10.77 /

-0.82 (-7.08%)

Skillsoft announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SKIL Skillsoft
$10.77 /

-0.82 (-7.08%)

Hot Stocks
Terns Pharmaceuticals reports results from phase 2a LIFT study of TERN-101 » 07:33
06/14/21
06/14
07:33
06/14/21
07:33
TERN

Terns Pharmaceuticals

$17.45 /

-2.02 (-10.37%)

Terns Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TERN Terns Pharmaceuticals
$17.45 /

-2.02 (-10.37%)

TERN Terns Pharmaceuticals
$17.45 /

-2.02 (-10.37%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
  • 05
    Feb
TERN Terns Pharmaceuticals
$17.45 /

-2.02 (-10.37%)

Recommendations
Regeneron's multiple bullish signals suggest return to growth, says Argus » 07:32
06/14/21
06/14
07:32
06/14/21
07:32
REGN

Regeneron

$525.71 /

-6.63 (-1.25%)

Argus analyst Jasper…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$525.71 /

-6.63 (-1.25%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

05/13/21 Needham
Graybug Vision downgraded to Hold from Buy at Needham
05/07/21 Morgan Stanley
Regeneron price target raised to $495 from $477 at Morgan Stanley
05/06/21 Piper Sandler
Regeneron remains top large cap pick, says Piper Sandler
04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
REGN Regeneron
$525.71 /

-6.63 (-1.25%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

REGN Regeneron
$525.71 /

-6.63 (-1.25%)

Recommendations
Dover earnings momentum intact, says JPMorgan » 07:31
06/14/21
06/14
07:31
06/14/21
07:31
DOV

Dover

$151.82 /

+1.59 (+1.06%)

JPMorgan analyst Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOV Dover
$151.82 /

+1.59 (+1.06%)

04/21/21 Deutsche Bank
Dover price target raised to $150 from $143 at Deutsche Bank
04/21/21 JPMorgan
Dover price target raised to $155 from $138 at JPMorgan
04/21/21 Barclays
Dover price target raised to $165 from $155 at Barclays
04/21/21 RBC Capital
Dover price target raised to $149 from $142 at RBC Capital
DOV Dover
$151.82 /

+1.59 (+1.06%)

DOV Dover
$151.82 /

+1.59 (+1.06%)

DOV Dover
$151.82 /

+1.59 (+1.06%)

Hot Stocks
Thoma Bravo Advantage urges holders to vote in favor of ironSource combination » 07:31
06/14/21
06/14
07:31
06/14/21
07:31
TBA

Thoma Bravo Advantage

$10.23 /

-0.035 (-0.34%)

Thoma Bravo Advantage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TBA Thoma Bravo Advantage
$10.23 /

-0.035 (-0.34%)

TBA Thoma Bravo Advantage
$10.23 /

-0.035 (-0.34%)

TBA Thoma Bravo Advantage
$10.23 /

-0.035 (-0.34%)

TBA Thoma Bravo Advantage
$10.23 /

-0.035 (-0.34%)

Hot Stocks
Avenue Therapeutics trading resumes  07:30
06/14/21
06/14
07:30
06/14/21
07:30
ATXI

Avenue Therapeutics

$4.23 /

-0.14 (-3.20%)

 
ShowHide Related Items >><<
ATXI Avenue Therapeutics
$4.23 /

-0.14 (-3.20%)

ATXI Avenue Therapeutics
$4.23 /

-0.14 (-3.20%)

04/14/21 B. Riley
Fortress Biotech weakness yesterday a buying opportunity, says B. Riley
03/01/21 H.C. Wainwright
InvaGen takeout 'may still be in play' at Avenue, says H.C. Wainwright
02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
10/12/20 H.C. Wainwright
Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright
ATXI Avenue Therapeutics
$4.23 /

-0.14 (-3.20%)

Upgrade
Boston Properties upgraded to Overweight from Neutral at Piper Sandler » 07:29
06/14/21
06/14
07:29
06/14/21
07:29
BXP

Boston Properties

$123.19 /

+0.56 (+0.46%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BXP Boston Properties
$123.19 /

+0.56 (+0.46%)

BXP Boston Properties
$123.19 /

+0.56 (+0.46%)

05/25/21 Goldman Sachs
Boston Properties assumed with a Sell at Goldman Sachs
05/04/21 Argus
Boston Properties price target raised to $120 from $100 at Argus
04/19/21 Deutsche Bank
Boston Properties price target raised to $107 from $103 at Deutsche Bank
04/14/21 Mizuho
Boston Properties price target raised to $107 from $86 at Mizuho
BXP Boston Properties
$123.19 /

+0.56 (+0.46%)

Initiation
iMedia Brands initiated with a Buy at B. Riley » 07:28
06/14/21
06/14
07:28
06/14/21
07:28
IMBI

iMedia Brands

$8.72 /

-0.28 (-3.11%)

B. Riley initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMBI iMedia Brands
$8.72 /

-0.28 (-3.11%)

IMBI iMedia Brands
$8.72 /

-0.28 (-3.11%)

05/26/21 Lake Street
iMedia Brands price target raised to $19 from $15 at Lake Street
05/25/21 Craig-Hallum
iMedia Brands price target raised to $20 from $15 at Craig-Hallum
03/23/21 Lake Street
iMedia Brands price target raised to $15 from $13 at Lake Street
02/11/21 DA Davidson
iMedia Brands price target raised to $19 from $12 at DA Davidson
IMBI iMedia Brands
$8.72 /

-0.28 (-3.11%)

  • 10
    Jun
  • 18
    Feb
  • 26
    Aug
IMBI iMedia Brands
$8.72 /

-0.28 (-3.11%)

Hot Stocks
G1 Therapeutics initiates PRESERVE 3, phase 2 study of cosela » 07:28
06/14/21
06/14
07:28
06/14/21
07:28
GTHX

G1 Therapeutics

$21.65 /

-0.25 (-1.14%)

, MKKGY

Merck KGaA

$37.59 /

-0.43 (-1.13%)

, PFE

Pfizer

$40.15 /

-0.54 (-1.33%)

G1 Therapeutics (GTHX)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTHX G1 Therapeutics
$21.65 /

-0.25 (-1.14%)

MKKGY Merck KGaA
$37.59 /

-0.43 (-1.13%)

PFE Pfizer
$40.15 /

-0.54 (-1.33%)

GTHX G1 Therapeutics
$21.65 /

-0.25 (-1.14%)

04/23/21 Cowen
G1 Therapeutics transferred with Outperform at Cowen
11/17/20 Raymond James
Raymond James downgrades G1 Therapeutics after removing rintodestrant from model
11/17/20 Raymond James
G1 Therapeutics downgraded to Outperform from Strong Buy at Raymond James
07/01/20 Wedbush
G1 Therapeutics price target lowered to $50 from $55 at Wedbush
MKKGY Merck KGaA
$37.59 /

-0.43 (-1.13%)

06/01/21 Berenberg
Merck KGaA price target raised to EUR 158 from EUR 150 at Berenberg
05/17/21 Deutsche Bank
Merck KGaA price target raised to EUR 155 from EUR 146 at Deutsche Bank
05/13/21 JPMorgan
Merck KGaA price target raised to EUR 165 from EUR 160 at JPMorgan
03/08/21 Morgan Stanley
Merck KGaA price target lowered to EUR 141 from EUR 143 at Morgan Stanley
PFE Pfizer
$40.15 /

-0.54 (-1.33%)

06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/01/21 Argus
Argus says market underestimating sustainability of Pfizer COVID vaccine program
05/18/21 William Blair
William Blair says continued lack of '9001 safety signals positive for Sarepta
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
GTHX G1 Therapeutics
$21.65 /

-0.25 (-1.14%)

PFE Pfizer
$40.15 /

-0.54 (-1.33%)

PFE Pfizer
$40.15 /

-0.54 (-1.33%)

PFE Pfizer
$40.15 /

-0.54 (-1.33%)

PFE Pfizer
$40.15 /

-0.54 (-1.33%)

Upgrade
Hudson Pacific upgraded to Overweight from Neutral at Piper Sandler » 07:27
06/14/21
06/14
07:27
06/14/21
07:27
HPP

Hudson Pacific

$29.73 /

-0.225 (-0.75%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPP Hudson Pacific
$29.73 /

-0.225 (-0.75%)

HPP Hudson Pacific
$29.73 /

-0.225 (-0.75%)

05/25/21 Goldman Sachs
Hudson Pacific assumed with a Buy at Goldman Sachs
04/16/21 Morgan Stanley
Morgan Stanley downgrades Hudson Pacific to Underweight on SF market challenges
04/16/21 Morgan Stanley
Hudson Pacific downgraded to Underweight from Equal Weight at Morgan Stanley
04/14/21 Mizuho
Hudson Pacific price target raised to $28 from $23 at Mizuho
HPP Hudson Pacific
$29.73 /

-0.225 (-0.75%)

Recommendations
OrthoPediatrics price target raised to $77 from $70 at Needham » 07:25
06/14/21
06/14
07:25
06/14/21
07:25
KIDS

OrthoPediatrics

$63.38 /

+0.02 (+0.03%)

Needham analyst Mike…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KIDS OrthoPediatrics
$63.38 /

+0.02 (+0.03%)

KIDS OrthoPediatrics
$63.38 /

+0.02 (+0.03%)

06/01/21 Piper Sandler
Piper Sandler 'strongly' encourages investors buy OrthoPediatrics
05/07/21 Truist
OrthoPediatrics price target raised to $72 from $64 at Truist
05/07/21 JMP Securities
OrthoPediatrics price target raised to $70 from $55 at JMP Securities
05/06/21 Piper Sandler
OrthoPediatrics price target raised to $70 from $62 at Piper Sandler
KIDS OrthoPediatrics
$63.38 /

+0.02 (+0.03%)

  • 18
    Jun
KIDS OrthoPediatrics
$63.38 /

+0.02 (+0.03%)

Initiation
Oatly Group initiated with a Neutral at JPMorgan » 07:25
06/14/21
06/14
07:25
06/14/21
07:25
OTLY

Oatly Group

$28.71 /

+2.01 (+7.53%)

JPMorgan analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

07:15 Today Truist
Oatly Group initiated with a Buy at Truist
07:02 Today William Blair
Oatly Group initiated with an Outperform at William Blair
06:36 Today Guggenheim
Oatly Group initiated with a Buy at Guggenheim
06:24 Today Truist
Oatly Group initiated with a Buy at Truist
  • 20
    May
OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

OTLY Oatly Group
$28.71 /

+2.01 (+7.53%)

Hot Stocks
Landos Biopharma announce outcome of End-of-Phase 2 meeting with FDA » 07:25
06/14/21
06/14
07:25
06/14/21
07:25
LABP

Landos Biopharma

$12.06 /

-0.03 (-0.25%)

Landos Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LABP Landos Biopharma
$12.06 /

-0.03 (-0.25%)

LABP Landos Biopharma
$12.06 /

-0.03 (-0.25%)

03/01/21 Jefferies
Landos Biopharma initiated with a Buy at Jefferies
03/01/21 JPMorgan
Landos Biopharma initiated with a Neutral at JPMorgan
03/01/21 Raymond James
Landos Biopharma initiated with an Outperform at Raymond James
03/01/21 SVB Leerink
Landos Biopharma initiated with an Outperform at SVB Leerink
LABP Landos Biopharma
$12.06 /

-0.03 (-0.25%)

  • 04
    Feb
LABP Landos Biopharma
$12.06 /

-0.03 (-0.25%)

Downgrade
UWM Holdings downgraded to Neutral at Wedbush on stock current value » 07:24
06/14/21
06/14
07:24
06/14/21
07:24
UWMC

UWM Holdings

$10.23 /

+0.545 (+5.63%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UWMC UWM Holdings
$10.23 /

+0.545 (+5.63%)

UWMC UWM Holdings
$10.23 /

+0.545 (+5.63%)

06:44 Today Wedbush
UWM Holdings downgraded to Neutral from Outperform at Wedbush
06/02/21 Credit Suisse
UWM Holdings downgraded to Neutral from Outperform at Credit Suisse
05/27/21 Argus
UWM Holdings initiated with a Buy at Argus
05/27/21 Argus
UWM Holdings initiated with a Buy at Argus
UWMC UWM Holdings
$10.23 /

+0.545 (+5.63%)

Initiation
Squarespace initiated with an Overweight at JPMorgan » 07:24
06/14/21
06/14
07:24
06/14/21
07:24
SQSP

Squarespace

$59.94 /

+2.04 (+3.52%)

JPMorgan analyst Sterling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQSP Squarespace
$59.94 /

+2.04 (+3.52%)

SQSP Squarespace
$59.94 /

+2.04 (+3.52%)

07:05 Today William Blair
Squarespace initiated with an Outperform at William Blair
06:43 Today Raymond James
Squarespace initiated with an Outperform at Raymond James
06:14 Today Piper Sandler
Squarespace initiated with a Neutral at Piper Sandler
06:12 Today RBC Capital
Squarespace initiated with a Sector Perform at RBC Capital
  • 19
    May
SQSP Squarespace
$59.94 /

+2.04 (+3.52%)

SQSP Squarespace
$59.94 /

+2.04 (+3.52%)

Hot Stocks
Enochian Biosciences announces FDA acceptance of pre-IND for potential HIV cure » 07:23
06/14/21
06/14
07:23
06/14/21
07:23
ENOB

Enochian Biosciences

$4.38 /

-0.02 (-0.45%)

Enochian BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENOB Enochian Biosciences
$4.38 /

-0.02 (-0.45%)

ENOB Enochian Biosciences
$4.38 /

-0.02 (-0.45%)

Initiation
Procore initiated with an Overweight at JPMorgan » 07:21
06/14/21
06/14
07:21
06/14/21
07:21
PCOR

Procore

$83.98 /

-2.47 (-2.86%)

JPMorgan analyst Sterling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCOR Procore
$83.98 /

-2.47 (-2.86%)

07:04 Today William Blair
Procore initiated with an Outperform at William Blair
06:21 Today Canaccord
Procore initiated with a Buy at Canaccord
06:15 Today Oppenheimer
Procore initiated with an Outperform at Oppenheimer
06:09 Today Piper Sandler
Procore initiated with an Overweight at Piper Sandler
  • 20
    May
PCOR Procore
$83.98 /

-2.47 (-2.86%)

PCOR Procore
$83.98 /

-2.47 (-2.86%)

Hot Stocks
iTeos Therapeutics, GlaxoSmithKline collaborate for EOS-448 » 07:21
06/14/21
06/14
07:21
06/14/21
07:21
ITOS

iTeos Therapeutics

$20.01 /

+0.11 (+0.55%)

, GSK

GlaxoSmithKline

$40.15 /

-0.07 (-0.17%)

iTeos Therapeutics (ITOS)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
04/12/21 Piper Sandler
iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler
GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
04/30/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,200 GBp at Deutsche Bank
ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

  • 24
    Jul
GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

Recommendations
PDC Energy price target raised to $65 from $51 at JPMorgan » 07:20
06/14/21
06/14
07:20
06/14/21
07:20
PDCE

PDC Energy

$47.79 /

+0.6 (+1.27%)

JPMorgan analyst Arun…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDCE PDC Energy
$47.79 /

+0.6 (+1.27%)

PDCE PDC Energy
$47.79 /

+0.6 (+1.27%)

02/25/21 JPMorgan
PDC Energy price target raised to $47 from $30 at JPMorgan
01/21/21 JPMorgan
PDC has roadmap to narrow discount to intrinsic value, says JPMorgan
01/21/21 Citi
PDC Energy price target raised to $30 from $21 at Citi
01/19/21 Cowen
PDC Energy price target raised to $33 from $27 at Cowen
PDCE PDC Energy
$47.79 /

+0.6 (+1.27%)

Initiation
Halozyme initiated with an Outperform at Evercore ISI » 07:20
06/14/21
06/14
07:20
06/14/21
07:20
HALO

Halozyme

$42.82 /

+1.09 (+2.61%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HALO Halozyme
$42.82 /

+1.09 (+2.61%)

HALO Halozyme
$42.82 /

+1.09 (+2.61%)

06/11/21 BMO Capital
Halozyme coverage transferred at BMO Capital
05/17/21 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
05/17/21 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
05/11/21 Piper Sandler
Halozyme downgraded to Neutral from Overweight at Piper Sandler
HALO Halozyme
$42.82 /

+1.09 (+2.61%)

HALO Halozyme
$42.82 /

+1.09 (+2.61%)

Initiation
Ingersoll-Rand reinstated with a Neutral at Credit Suisse » 07:19
06/14/21
06/14
07:19
06/14/21
07:19
IR

Ingersoll-Rand

$47.92 /

+0.52 (+1.10%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IR Ingersoll-Rand
$47.92 /

+0.52 (+1.10%)

IR Ingersoll-Rand
$47.92 /

+0.52 (+1.10%)

05/19/21 Deutsche Bank
Deutsche Bank upgrades 'laggard' Ingersoll-Rand to Buy
05/19/21 Deutsche Bank
Ingersoll-Rand upgraded to Buy from Hold at Deutsche Bank
05/12/21 Evercore ISI
Ingersoll-Rand price target raised to $53 from $48 at Evercore ISI
04/06/21 Barclays
Ingersoll-Rand price target raised to $56 from $53 at Barclays
IR Ingersoll-Rand
$47.92 /

+0.52 (+1.10%)

  • 11
    May
  • 17
    Jun
IR Ingersoll-Rand
$47.92 /

+0.52 (+1.10%)

IR Ingersoll-Rand
$47.92 /

+0.52 (+1.10%)

Upgrade
Krung Thai Bank upgraded to Neutral from Underweight at JPMorgan » 07:19
06/14/21
06/14
07:19
06/14/21
07:19
KTHAF

Krung Thai Bank

/

+

JPMorgan analyst Harsh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KTHAF Krung Thai Bank
/

+

09/09/20 Goldman Sachs
Krung Thai Bank upgraded to Neutral from Sell at Goldman Sachs

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.